INS and metabolic dysfunction-associated steatotic liver disease: All traditional cardiovascular and metabolic risk factors (age, male sex, lipid profile, fasting glucose, insulin, homeostatic model assessment of insulin resistance [HOMA-IR], blood pressure, and smoking) were more adversely affected in participants with NAFLD than in those without NAFLD.